These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9072425)

  • 1. Enalapril improves glucose tolerance in two rat models: a new hypertensive diabetic strain and a fructose-induced hyperinsulinaemic rat.
    Rosenthal T; Erlich Y; Rosenmann E; Grossman E; Cohen A
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S353-4. PubMed ID: 9072425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat.
    Erlich Y; Rosenthal T
    Hypertension; 1996 Nov; 28(5):754-7. PubMed ID: 8901819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibitors on fructose induced hypertension and hyperinsulinaemia in rats.
    Erlich Y; Rosenthal T
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S347-9. PubMed ID: 9072423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat.
    Rosenthal T; Erlich Y; Rosenmann E; Cohen A
    Hypertension; 1997 Jun; 29(6):1260-4. PubMed ID: 9180626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats.
    Elkayam A; Mirelman D; Peleg E; Wilchek M; Miron T; Rabinkov A; Sadetzki S; Rosenthal T
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):377-81. PubMed ID: 11336185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
    Iimura O; Shimamoto K; Matsuda K; Masuda A; Takizawa H; Higashiura K; Miyazaki Y; Hirata A; Ura N; Nakagawa M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):353-7. PubMed ID: 7619347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia and insulin resistance in hypertension: differential effects of antihypertensive agents.
    Goyal RK
    Clin Exp Hypertens; 1999; 21(1-2):167-79. PubMed ID: 10052652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat.
    Erlich Y; Rosenthal T
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):581-4. PubMed ID: 9554808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
    Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
    Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes.
    Sato Y; Iwase M; Wakisaka M; Yoshizumi H; Nunoi K; Yoshinari M; Fujishima M
    Diabetes Res Clin Pract; 1995 Sep; 29(3):153-61. PubMed ID: 8591707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects of a low protein diet and angiotensin converting enzyme inhibitors on renal insufficiency in hypertensive rats].
    Cervenka L; Heller J
    Cas Lek Cesk; 1996 May; 135(10):305-7. PubMed ID: 8697492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril.
    Sugimoto K; Tsuruoka S; Fujimura A
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):601-7. PubMed ID: 10474773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
    Kamari Y; Harari A; Shaish A; Peleg E; Sharabi Y; Harats D; Grossman E
    Hypertens Res; 2008 Jan; 31(1):135-40. PubMed ID: 18360028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential efficacy of perindopril and enalapril in experimental diabetic nephropathy.
    Duggan KA; Hodge G; Makarious MM; Charlesworth JA
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):608-10. PubMed ID: 8800600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
    Duggan KA; Hodge G; Makarious MM; Charlesworth JA
    Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.